Pharmacovigilance Services: Market Size & Forecast 2026

The global pharmacovigilance services market reached approximately USD 9.5 billion in 2025, held in a structurally tight balance between accelerating post-marketing safety obligations, a wave of pharmaceutical M&A demanding post-merger PV integration, and chronic shortages of Qualified Person for Pharmacovigilance (QPPV) talent across major markets. We project the market will reach roughly USD 19.1 billion by 2032 at a 10.5% CAGR, though that headline masks a bifurcated reality: traditional case-processing volume grows near 8% while AI-augmented signal-detection and pharmacovigilance software segments expand at 14-16%. > **Analyst Take.** The consensus 10.5% CAGR is directionally right but the composition is wrong. Roughly 40% of the growth comes from M&A-driven integration work, not organic demand expansion. The call is not to chase headline growth but to position procurement for a post

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.